Find and Pitch Jounalists, Get Your Story Covered

Tags: statins statin lipid statin therapy kidney disease

	Profile	Recent Articles on Subject
1	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Generic GLP-1 drugs could help Medicare drive a harder bargain for Ozempic and Wegovy - 7 days ago
2	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: Ionis blazed trails in genetic medicine. On the cusp of a major approval, can it also be a commercial success? - about 1 month ago STAT+: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease - 7 months ago
3	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: Ionis blazed trails in genetic medicine. On the cusp of a major approval, can it also be a commercial success? - about 1 month ago
4	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Amgen drug leads to substantial weight loss in study, but questions remain about competitiveness - about 2 months ago STAT+: A second Roche obesity drug shows promise in early studies - 6 months ago STAT+: What comes after Wegovy? The quest to eradicate obesity - about 1 year ago STAT+: Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial - over 1 year ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Arrowhead Pharmaceuticals Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome - about 2 months ago FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins - 10 months ago Statins Could Potentially Slow Deterioration of Cognitive Function for Those With Alzheimer Disease - about 1 year ago Study: Statin Use Associated With Reduced Breast Cancer Mortality - about 1 year ago Study: Cholesterol in Brain Associated Alzheimer Disease, Brain Damage - about 1 year ago
6	David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK Technologysciencewriting	Common Heart Meds May Sharply Reduce Dementia Risk, Study Says - about 2 months ago A Game-Changing Vaccine Could Lower 'Bad' Cholesterol by 30% - about 1 year ago
7	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	More Lp(a)-Reducing Tx; Cardiac Denervation for Afib; LAA Occluders at 5 Years - about 2 months ago Beta-Blockers Fail to Deliver Secondary Prevention Benefit in Key MI Patients - 9 months ago Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication - 10 months ago Statins and CKD; Farxiga's Limited Symptom Improvement; Stop Wasted TNKase - about 1 year ago Alleged Stroke Trial Misconduct; Ultrasound Tx for Severe AS; Farxiga's eGFR Drops - about 1 year ago Statins Reach More Patients With Pharmacist's Orders - about 1 year ago Novel PCSK9 Inhibitor Recaticimab Lowers Lipids With Less Frequent Shots - about 1 year ago Promising Debut for CRISPR Gene Editing Therapy for LDL Lowering - about 1 year ago Highly Potent Statin Stands Out for Diabetes, Cataract Risks - about 1 year ago FXI Inhibitor Cuts Bleeds in Afib; COAPT Extends to Real World; AI Stroke Triage - over 1 year ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more - about 2 months ago STAT+: Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more - 3 months ago STAT+: A drug may cause problems with chemotherapies in cancer patients with obesity. Many doctors are in the dark - 3 months ago STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 4 months ago STAT+: Pharmalittle: We’re reading about a Vaxcyte vaccine, Ozempic shortages, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - 5 months ago STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more - 6 months ago STAT+: A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down - 6 months ago STAT+: Pharmalittle: We’re reading about a study of Ozempic and dementia, smaller PBMs, and more - 6 months ago STAT+: Pharmalittle: We’re reading about an Amgen obesity drug, a Senate bill on shortages, and more - 9 months ago STAT+: Pharmalittle: We’re reading about a GLP-1 side effect, U.K. clinical trial transparency, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Wegovy approved for heart risks, an ALS drug puzzle, and more - 10 months ago STAT+: Pharmalittle: We’re reading about GLP-1 drugs’ safety, Novartis nixing a deal, and more - about 1 year ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - about 1 year ago STAT+: Pharmalittle: Wegovy cuts heart attack risk in milestone trial; AstraZeneca prioritizes U.S. for RSV drug amid surge - about 1 year ago STAT+: Pharmalittle: Sarepta Duchenne therapy misses primary endpoint; FDA holds panel for first CRISPR treatment for sickle cell - about 1 year ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - about 1 year ago STAT+: Pharmalittle: FDA panel lacks confidence in Amgen cancer drug data; weight loss drugs linked to rare stomach problems - over 1 year ago
9	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: With new Wegovy data in hand, Novo Nordisk will file for approval in MASH - 2 months ago STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 4 months ago STAT+: Amgen goes all in on injectable obesity drug as it scraps early-stage pill - 9 months ago STAT+: Alnylam’s twice-a-year drug lowered blood pressure when combined with common pills - 9 months ago STAT+: Obesity drug Wegovy gets FDA approval to add cardiovascular benefits on its label - 10 months ago STAT+: What comes after Wegovy? The quest to eradicate obesity - about 1 year ago STAT+: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds - about 1 year ago STAT+: Even as Wegovy rides high, interest surges in weight loss drugs that preserve muscle - about 1 year ago STAT+: Anthos stroke drug appears safer than common blood thinner in mid-stage trial - about 1 year ago
10	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Grants Breakthrough Therapy Designation to Plozasiran for Familial Chylomicronemia Syndrome - 4 months ago

Journalists covering statins